Does trazodone 250 mg effectively treat depression in adults?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Trazodone 250mg is NOT recommended as a first-line treatment for depression, though it can be effective at this dose when used appropriately

The American Academy of Sleep Medicine explicitly recommends AGAINST using trazodone for depression treatment as a primary option 1. While trazodone is FDA-approved for major depressive disorder (MDD) 2, the evidence supporting its efficacy is weak compared to other antidepressants, and clinical guidelines consistently place it lower in treatment algorithms.

Evidence Quality and Positioning

The 2017 AASM Clinical Practice Guideline provides a conditional recommendation AGAINST trazodone for insomnia based on trials of 50mg doses, citing insufficient evidence 1. While this guideline focused on insomnia rather than depression, it reflects the overall weak evidence base for trazodone.

For depression specifically:

  • Trazodone is FDA-approved for MDD treatment 2
  • The typical antidepressant dose range is 150-300mg daily 3, making 250mg within the therapeutic range
  • However, multiple guidelines position trazodone as a third-line option, recommended only after benzodiazepine receptor agonists fail and primarily when comorbid depression/anxiety exists 3

When Trazodone 250mg May Be Appropriate

Consider trazodone 250mg for depression when:

  • First-line SSRIs or SNRIs have failed or caused intolerable side effects
  • The patient has comorbid insomnia requiring treatment 3
  • Sexual dysfunction from SSRIs is problematic (trazodone has lower risk) 4
  • The patient cannot tolerate anticholinergic effects of tricyclics 5

Research evidence shows trazodone 250mg can be effective - one comparative trial found it equivalent to fluoxetine for depression, with the median sustained dose being exactly 250mg 6. Long-term studies demonstrate continued efficacy over 12 months 5.

Critical Dosing Considerations

The 250mg dose should be:

  • Taken shortly after a meal or light snack to optimize absorption 2
  • Built up gradually from lower starting doses
  • Monitored for orthostatic hypotension, especially in elderly patients 3
  • Assessed for drowsiness/sedation that may require dose timing adjustment 2

Comparative Effectiveness

Recent research suggests trazodone extended-release may produce larger effect sizes than SSRIs across depression, anxiety, and sleep domains 7. However, this represents newer formulation data not yet incorporated into major guidelines.

The 2023 American College of Physicians systematic review found similar benefits among most antidepressants as first-step treatments, but noted low certainty of evidence for most comparisons 8. This equipoise supports individualized selection based on side effect profiles rather than efficacy alone.

Safety Warnings

Monitor for:

  • Orthostatic hypotension - particularly dangerous in elderly or those with cardiovascular disease 3
  • QT prolongation - dose-dependent risk of cardiac arrhythmias 9, 4
  • Priapism - rare but serious adverse effect requiring immediate attention 2, 4
  • Suicidal ideation - standard monitoring for all antidepressants, especially in young adults 2

Contraindications

Do not use trazodone if:

  • Taking MAOIs or within 2 weeks of MAOI discontinuation 2
  • Severe hepatic impairment present
  • History of priapism

Bottom Line Algorithm

For treating depression with trazodone 250mg:

  1. First, try: SSRIs (escitalopram, sertraline) or SNRIs (venlafaxine, duloxetine) as first-line per standard guidelines
  2. If first-line fails or causes sexual dysfunction/insomnia: Consider trazodone 150-300mg
  3. Start low: Begin at 50-100mg and titrate up to 250mg over 2-4 weeks
  4. Take with food: Shortly after meals to reduce side effects and improve absorption
  5. Monitor closely: Blood pressure (especially orthostatic), cardiac function if risk factors present, and suicidality in first 4-8 weeks
  6. Assess response: Allow 4-6 weeks at therapeutic dose before determining efficacy
  7. If partial response: Can increase to 300mg or augment with psychotherapy

The evidence supports trazodone 250mg as an effective antidepressant dose, but it should not be your first choice - reserve it for patients who have failed or cannot tolerate first-line agents, or when comorbid insomnia makes its sedating properties advantageous 3, 1.

References

Guideline

clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: an american academy of sleep medicine clinical practice guideline.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2017

Guideline

clinical guideline for the evaluation and management of chronic insomnia in adults.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2008

Research

Long-term therapy for depression with trazodone.

The Journal of clinical psychiatry, 1983

Research

Fluoxetine versus trazodone: efficacy and activating-sedating effects.

The Journal of clinical psychiatry, 1991

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.